Quality of life and tolerability in patients with schizophrenia taking atypical antipsychotics

被引：10
|
作者：
Fleming, K. [1 ]
Potkin, S. G. [1 ]
Binneman, B. [2 ]
Keller, D. [3 ]
Alphs, L. [4 ]
Panagides, J.
机构：
[1] Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA
[2] Pfizer Inc, Clin R&D, Groton, CT USA
[3] Pfizer Inc, Clin Pharmacol & Stat, Groton, CT USA
[4] Pfizer Inc, Global R&D, Ann Arbor, MI USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70710-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S466 / S467
页数：2
相关论文
共 50 条
  • [41] Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review
    Canas, Fernando
    Moeller, Hans-Juergen
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (05) : 683 - 697
  • [42] Typical and atypical antipsychotics in adolescent schizophrenia: Efficacy, tolerability, and differential sensitivity to extrapyramidal symptoms
    Lewis, R
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1998, 43 (06): : 596 - 604
  • [43] Atypical antipsychotics in the treatment of schizophrenia - Validity of dropout rates as proxy measure of tolerability is unknown
    Rowsell, R
    Link, C
    Donoghue, J
    BRITISH MEDICAL JOURNAL, 2001, 322 (7291): : 925 - 925
  • [44] Atypical antipsychotics and cognition in schizophrenia
    Sharma, T
    ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (06) : 571 - 572
  • [45] Refractory schizophrenia and atypical antipsychotics
    Taylor, DM
    Duncan-McConnell, D
    JOURNAL OF PSYCHOPHARMACOLOGY, 2000, 14 (04) : 409 - 418
  • [46] Atypical antipsychotics in the treatment of schizophrenia
    Bridler, R
    Umbricht, D
    SWISS MEDICAL WEEKLY, 2003, 133 (5-6) : 63 - 76
  • [47] The prognostic of schizophrenia and atypical antipsychotics
    Podea, D
    Nanu, PD
    Chenderes, RM
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S488 - S488
  • [48] Bipolar disorder: Quality of life and the impact of atypical antipsychotics
    Vornik, LA
    Hirschfeld, RMA
    AMERICAN JOURNAL OF MANAGED CARE, 2005, 11 (09): : S275 - S280
  • [49] Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission
    Yen, Cheng-Fang
    Cheng, Chung-Ping
    Huang, Chi-Fen
    Yen, Ju-Yu
    Ko, Chih-Hung
    Chen, Cheng-Sheng
    BIPOLAR DISORDERS, 2008, 10 (05) : 617 - 624
  • [50] Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics-The Pilot Case Series Study
    Krzystanek, Marek
    Warchala, Anna
    Tredzbor, Beata
    Martyniak, Ewa
    Skalacka, Katarzyna
    Palasz, Artur
    PHARMACEUTICALS, 2021, 14 (10)
12345